Search

everythinglearnresearchcommunity

for

Search:↓

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Effective acne treatment varies by type, with topical and oral medications showing strong evidence, and patient education and support are crucial.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Dengue fever can cause hair loss that may lead to serious psychological issues like Body Dysmorphic Disorder in young women.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Hair care products are important for appearance and self-esteem, and choosing the right ones can help maintain healthy hair.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.